Atrazine (ATZ; 2-chloro-4-ethylamino-6-isopropylamino-*s*-triazine) is a systemic triazine herbicide that blocks photosynthesis in broadleaf weeds and some grassy weeds ([@b34-ehp0115-001474]). ATZ is currently one of the two most widely used agricultural pesticides in the United States, although from 1985 to 2001, it was the most abundantly applied pesticide ([@b25-ehp0115-001474]; [@b33-ehp0115-001474]). Approximately 64--80 million pounds of ATZ are applied annually in the United States for agricultural and residential purposes; this amount has remained relatively constant over the past few decades ([@b33-ehp0115-001474]).

ATZ has been used predominantly in the Midwest ([@b39-ehp0115-001474]). About three-fourths of all field corn and sorghum are treated with ATZ annually for weed control. Seventy percent of the ATZ applied to corn and sorghum is used as a preemergence herbicide, and 30% is applied postemergence. ATZ is also used for weed control in sugarcane and wheat fields. In addition to agricultural uses, ATZ is used in residential turf applications in the Southeast, including use on golf courses and sod farms to control weeds ([@b39-ehp0115-001474]).

ATZ and its degradates are the most commonly detected pesticide(s) in ground and surface waters ([@b1-ehp0115-001474]; [@b6-ehp0115-001474]; [@b9-ehp0115-001474]; [@b10-ehp0115-001474]; [@b11-ehp0115-001474]; [@b13-ehp0115-001474]; Clark and Clay et al. 2000; Goolsby 2000; [@b29-ehp0115-001474]). It has been the subject of multiple monitoring programs conducted by various industry and government agencies, especially the U.S. Geological Survey (USGS) ([@b9-ehp0115-001474]). The frequent detection of ATZ and its degradates in streams, rivers, groundwater, and reservoirs is related directly to its volume of use, its tendency to persist in soils because of its resistance to photolysis and hydrolysis, and its ability to travel with water systems ([@b39-ehp0115-001474]). In water systems, ATZ typically undergoes dealkylation to form desethylatrazine (DEA), desisopropylatrazine (DIA), and the terminal dealklylation product diaminochlorotriazine (DACT) ([@b39-ehp0115-001474]) ([Figure 1](#f1-ehp0115-001474){ref-type="fig"}). In plants, ATZ is absorbed by the root system and tends to form hydroxylated metabolites that cannot generally be removed by washing of the vegetable products. Studies reported to the U.S. Environmental Protection Agency (EPA) have suggested that in animals the degradation products that retain the chlorine have biological activity similar to that of atrazine, whereas the hydroxylated metabolites do not retain their biological activity ([@b39-ehp0115-001474]). The biological end points observed in animals have been primarily endocrine-mediated, for example, affecting hypothalamic control of pituitary--ovarian function by modulation of luteinizing hormone release ([@b23-ehp0115-001474]; [@b30-ehp0115-001474]; [@b38-ehp0115-001474]) and mammary tumor production ([@b26-ehp0115-001474], [@b27-ehp0115-001474]; [@b40-ehp0115-001474]; [@b44-ehp0115-001474]; [@b45-ehp0115-001474]). ATZ has also been reported to modulate aromatase activity *in vivo* and *in vitro* ([@b24-ehp0115-001474]; [@b32-ehp0115-001474]) potentially resulting in hermaphroditic amphiphibians ([@b31-ehp0115-001474]), although this health outcome has been debated ([@b28-ehp0115-001474]; [@b43-ehp0115-001474]).

Metabolism of ATZ and its degradation products is a complex process resulting in multiple potential metabolites ([Figure 1](#f1-ehp0115-001474){ref-type="fig"}). Many human and animal studies have evaluated ATZ metabolism and the conclusions are variable ([Table 1](#t1-ehp0115-001474){ref-type="table"}). Some rat and human studies identified DACT as the primary metabolite of ATZ ([@b8-ehp0115-001474]; [@b16-ehp0115-001474], [@b14-ehp0115-001474]). Other human studies identified atrazine mercapturate (AM) ([Figure 1](#f1-ehp0115-001474){ref-type="fig"}), a glutathione-derived metabolite, as the predominant metabolite ([@b12-ehp0115-001474]; [@b36-ehp0115-001474]; [@b41-ehp0115-001474]). In total, 8--12 ATZ metabolites have been identified or postulated ([@b8-ehp0115-001474]; [@b12-ehp0115-001474]; [@b16-ehp0115-001474], [@b14-ehp0115-001474]; [@b41-ehp0115-001474]).

The latter human studies led us to focus our efforts mainly on measuring AM during biomontoring in the pilot phase of the Agricultural Health Study (ca. 1994; [@b5-ehp0115-001474]). AM was frequently detected in the urine of farmer applicators, their spouses, and sometimes children, typically at the highest concentrations on the day after ATZ application (WJ Driskell, unpublished data, 1995). Subsequently, we began measuring AM to evaluate environmental exposures to ATZ; however, this approach limited our ability to detect total exposure to ATZ-related compounds. In the Centers for Disease Control and Prevention (CDC) *National Report on Human Exposure to Environmental Chemicals* ([@b17-ehp0115-001474], [@b18-ehp0115-001474], [@b19-ehp0115-001474]), AM, the only ATZ metabolite measured, was typically detected in \< 5% of participants, which did not correspond with its widespread use and frequent detection in ground, surface, and municipal water systems. Similarly, other studies reported low frequencies of detection (e.g., \< 3%) of AM ([@b3-ehp0115-001474]; [@b35-ehp0115-001474]; [@b37-ehp0115-001474]), even though one of these studies reported frequent detection of ATZ in homes ([@b35-ehp0115-001474]).

The objective of our study was to evaluate multiple metabolites of ATZ in persons exposed in occupational and environmental scenarios. We wanted to determine if measurement of one metabolite was sufficient to estimate ATZ exposure relative to that in other individuals or whether multiple chemicals must be measured to accurately assess exposure to ATZ.

Experiment
==========

A detailed description of the analytical method can be found in [@b42-ehp0115-001474]. Briefly, we introduced 200 μL urine onto a dual online solid-phase extraction (reversed-phase phenyl--hexyl and strong cation exchange) system, which was operated by a novel switching mechanism. Analytes were preconcentrated using high-performance liquid chromatography on a guard column, and the remaining urine components were washed off, using 10% methanol in 0.1% formic acid, into a waste container. The valves were switched, and the analytes were backwashed onto a reversed-phase or strong anion exchange analytic column and separated using a linear gradient beginning with 10% methanol in 0.1% formic acid and ending with 100% methanol. Samples were analyzed using atmospheric pressure chemical ionization--tandem mass spectrometry with one precursor--product ion pair being used for quantification and two precursor--product ion pairs being used for confirmation ([Table 2](#t2-ehp0115-001474){ref-type="table"}). Quantification was achieved using isotope dilution calibration, for which isotopically labeled standards were available. When they were not available, the most closely eluting labeled standard was used for quantification. Each analytical run consisted of a full eight-standard calibration set, three positive (i.e., fortified urine samples at three levels spanning calibration range) and two negative (i.e., blank) control samples, and up to 75 unknown samples. The limits of detection ranged from 0.1 to 1 ng/mL, with relative standard deviations typically \< 12% over the calibration range.

Human samples were collected from residential turf applicators (i.e., commercial lawn care applicators), nonapplicators with low-level exposures (i.e., nonoccupationally exposed individuals with documented ATZ exposure based upon detectable levels of AM in their urine) and volunteers in Georgia with no known acute exposure to ATZ. All samples were collected as part of previous studies and were reanalyzed to determine total metabolites. All protocols were reviewed and approved by the CDC Institutional Review Board for ethical treatment of human research subjects. Samples were stored at −70°C until used and before analysis were thawed at room temperature and mixed thoroughly.

Simple statistics (mean, standard deviation, and ratios) were performed using Excel software (Microsoft, San Jose, CA). Because the number of samples tested was small, no significance testing was performed.

Results
=======

A mass chromatogram of a spiked urine sample is shown in [Figure 2](#f2-ehp0115-001474){ref-type="fig"}. Because the most polar analytes were not adequately retained on the reversed-phase column, a strong cation exchange column was used. DACT was partially retained on the reversed-phase column, and the remainder was retained on the strong cation exchange column resulting in two peaks for DACT. Both peaks were summed to calculate the total amount of DACT present. All peaks were resolved by either time or mass-to-charge ratio.

The metabolite profile of the higher exposure category of turf applicators is shown in [Figure 3](#f3-ehp0115-001474){ref-type="fig"} (*n* = 8). The two graphs represent the exposure assessment using only AM and the exposure assessment using all metabolites. DACT was the most predominantly detected metabolite (mean = 51%), followed closely by DEA (mean = 31%). AM was detected on average in only 12% of the samples tested. The interperson variation (calculated as the relative standard deviation of the percentage of each metabolite percentage among persons) in urinary concentrations among these most detected analytes was between 33 and 51%. The interperson variability was much greater for the less frequently detected metabolites.

The metabolite profiles for the lower-level exposure category (*n* = 5) are shown in [Figure 4](#f4-ehp0115-001474){ref-type="fig"}. On average, DEA (33%) and DACT (28%) were detected in about equal proportions, with only 6% detection of AM. Similar to the higher-level exposures, the interperson variation in their urinary concentrations was large.

For the environmental exposure category, DACT was by far the most predominantly detected metabolite (77%). DEA was detected the next most frequently (15%) and AM was detected in only 2% of the samples. Again, the interperson variability in metabolic profile concentrations was large.

Discussion
==========

The small amount of data that we present here clearly demonstrate that exposure to ATZ-related chemicals can be misrepresented by measurement of AM alone. However, it is important to note that the measurement of ATZ or AM in urine would be the only unequivocal indication that a person was exposed to ATZ and not an environmental degradate.

Also, the metabolite profiles differ dramatically based upon the exposure scenario ([Figure 5](#f5-ehp0115-001474){ref-type="fig"}). Occupational or lower-level acute exposures, perhaps after ATZ use on lawns, are probably more likely to be direct exposures to ATZ and lesser exposures to the degradation products. However, the environmental exposure scenario is quite different. In environmental exposures, persons likely are exposed through food or water, which would mean that dealkylation and hydrolysis products might make up a larger percentage of the exposure. Of course, exposure to the dealkylation products is still important because these chemicals remain biologically active. Thus, the presence of the chlorinated dealkylation products or their glutathione-mediated mercapturic acid metabolites would indicate exposure to a biologically active component. Presence of the hydroxylated metabolites may indicate exposure to the hydroxylated products themselves or to their chlorinated counterparts.

Our data demonstrate that we likely will need to measure most or all metabolites of ATZ to accurately assess ATZ-related exposures. However, further evaluation is necessary because of our small sample size and because the possible presence of glucuronide metabolites was not considered. In the future, we will explore further the role of hydroxyl metabolites in the metabolite profiles by evaluating glucuronide-hydrolyzed urine. Also, we need to include the mercapturates of the dealkylation products in our methodology to glean the full picture of ATZ metabolism. Futhermore, we will use this method to evaluate larger populations with high-level occupational exposures (e.g., manufacturers, farmers) and background exposures in the general U.S. population.

Although we found detectable concentrations of ATZ metabolites in most of the urine samples tested, we are uncertain what, if any, health effects result from these levels of exposure. In general, animal dosing studies that have investigated health effects ([@b7-ehp0115-001474]; [@b22-ehp0115-001474], [@b23-ehp0115-001474]) have used doses much larger than those to which we could assume (from back calculation) participants were exposed in our study. Further studies evaluating health outcomes at typical human exposure levels are warranted.

Conclusions
===========

We have clearly been underestimating exposure to ATZ-related metabolites in the U.S. population and in other selected studies. Our newer data are more in line with exposures we might expect to see based upon ATZ use and environmental persistence. It is likely that multiple metabolites must be measured to accurately classify exposure categories. Although DACT appeared to be the predominant metabolite detected in each exposure category, the interperson variations in its concentrations were consistently about 30%. Regardless, DACT and DEA appear to be the most important metabolites to measure to evaluate exposures to ATZ-related chemicals.

Clearly, exposure to ATZ or its degradates appears more pervasive than previously believed; however, more data are needed to confirm this observation. Where measures exist to mitigate or lessen exposures to biologically active ATZ degradates such as the use of high efficiency filters in municipal water systems or other mitigation strategies for pond and surface waters ([@b2-ehp0115-001474]; [@b4-ehp0115-001474]), they should be used to ensure the best protection of public health.

C[orrection]{.smallcaps}
========================

The percent contribution for "Low-level acute exposures" in [Figure 5](#f5-ehp0115-001474){ref-type="fig"} was changed from that in the original manuscript published online.

The opinions presented in this article are strictly the opinions of the authors and do not reflect official views of the Centers for Disease Control and Prevention.
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![. Proposed metabolism of ATZ. ATZ is shown in black; dealkylated metabolites are shown in green; hydroxylated metabolites are shown in blue; and glutathione-derived mercapturic acid metabolites are shown in red. Abbreviations: ATZ, atrazine; ATZ-OH, hydroxyatrazine; AM, atrazine mercapturate; DACT, diaminochlorotriazine; DATM, diaminotriazine mercapturate; DEA, desethylatrazine; DEAM, desethylatrazine mercapturate; DEA-OH, hydroxydesethylatrazine; DIA, desisopropyl atrazine; DIAM, desisopropylatrazine mercapturate.](ehp0115-001474f1){#f1-ehp0115-001474}

![Mass chromatogram of metabolites measured. AM, atrazine mercapturate; ATZ, atrazine; ATZ-OH, hydroxyatrazine; DACT, diaminochlorotriazine; DEA, desethylatrazine; DEAM, desethylatrazine mercapturate; DEA-OH, hydroxydesethylatrazine; DIA, desisopropyl atrazine; DIA-OH, hydroxydesisopropylatrazine; SCX, strong cation exchange.](ehp0115-001474f2){#f2-ehp0115-001474}

![Metabolite profile of turf applicators using just AM and multiple metabolites. AM, atrazine mercapturate; ATZ, atrazine; ATZ-OH, hydroxyatrazine; DACT, diaminochlorotriazine; DEA, desethylatrazine; DEA-OH, hydroxydesethylatrazine; DIA, desisopropyl atrazine.](ehp0115-001474f3){#f3-ehp0115-001474}

![Metabolite profile of lower level exposures using AM and multiple metabolites. Abbreviations: AM, atrazine mercapturate; ATZ, atrazine; ATZ-OH, hydroxyatrazine; DACT, diaminochlorotriazine; DEA, desethylatrazine; DEA-OH, hydroxydesethylatrazine; DIA, desisopropyl atrazine; DIA-OH, hydroxydesisopropylatrazine.](ehp0115-001474f4){#f4-ehp0115-001474}

![Average percent contribution of each metabolite to the total atrazine-related metabolite level for high, lower, and environmental exposures. Abbreviations: ATZ, atrazine; ATZ-OH, hydroxyatrazine; AM, atrazine mercapturate; DACT, diaminochlorotriazine; DEA, desethylatrazine; DEA-OH, hydroxydesethylatrazine; DIA, desisopropyl atrazine.](ehp0115-001474f5){#f5-ehp0115-001474}

###### 

Summary of animal and human metabolite studies.[a](#tfn2-ehp0115-001474){ref-type="table-fn"}

  Study                                                       Model       DACT    DIA     DEA     AM   ATZ     DAtM       ATZ-OH   Ammeline
  ----------------------------------------------------------- ----------- ------- ------- ------- ---- ------- ---------- -------- ----------
  Novartis[b](#tfn3-ehp0115-001474){ref-type="table-fn"}      Rat         1       Minor   Minor   ND   ND      1          ND       ND
  Bakke ([@b8-ehp0115-001474])                                Rat         ND      1       1       ND   ND      ND         1        1
  DE Bradway[b](#tfn3-ehp0115-001474){ref-type="table-fn"}    Rat         1       1       1       NA   NA      NA         1        1
  LL Erickson[b](#tfn3-ehp0115-001474){ref-type="table-fn"}   Swine       NA      NA      1       NA   NA      NA         NA       NA
  Novartis[b](#tfn3-ehp0115-001474){ref-type="table-fn"}      Monkey      1       4       2       3    ND      After iv   ND       ND
  Catenacci ([@b14-ehp0115-001474])                           Human       1       Minor   Minor   NA   Minor   NA         NA       NA
  Lucas ([@b36-ehp0115-001474])                               Human (D)   Minor   Minor   Minor   1    NA      NA         NA       NA
  Buchholz ([@b12-ehp0115-001474])                            Human (D)   2?      Minor   NA      1    NA      2?         NA       NA
  Perry ([@b41-ehp0115-001474])                               Human       NA      NA      2       1    NA      NA         NA       NA
  Catenacci ([@b15-ehp0115-001474])                           Human       1       Minor   2       NA   Minor   NA         NA       NA

Abbreviations: AM, atrazine mercapturate; ATZ, atrazine; ATZ-OH, hydroxyatrazine; DACT, diaminochlorotriazine; DATM, diaminotriazine mercapturate; DEA, desethylatrazine; DIA, desisopropyl atrazine; ND, not detected; NA, not measured or applicable to the study; ?, metabolite with tentative identification; (D), dermal exposure. "After iv" indicates that metabolite was seen only after iv administration of atrazine.

1, a major metabolite; 2, a less abundant metabolite; minor, minor metabolite identified.

Information obtained from documentation of internal studies conducted at Novartis. Information was kindly supplied by Novartis upon request by CDC.

###### 

Precursor--product ion pairs for tandem mass spectrometry of each analyte.[a](#tfn5-ehp0115-001474){ref-type="table-fn"}

                 Productions         
  -------- ----- ------------- ----- -----
  ATZ-OH   198   86            156   69
  DACT     146   79            68    62
  DEAM     315   185           144   102
  DIA      174   68            132   104
  DEA      188   146           104   110
  AM       343   214           102   172
  ATZ      216   174           104   68

Abbreviations: AM, atrazine mercapturate; ATZ-OH, hydroxyatrazine; ATZ, atrazine; C1, confirmation ion 1; C2, confirmation ion 2; \[M+H\], pseudomolecular ion derived from atmospheric pressure chemical ionization; DACT, diaminochlorotriazine; DATM, diaminotriazine mercapturate; DEA, desethylatrazine; DEAM, desethylatrazine mercapturate; DIA, desisopropyl atrazine; Q, quantification ion.

More details on the method are found in [@b42-ehp0115-001474].
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